Skip to main content

Agios Pharmaceuticals, Inc.

AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001439222

In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.46B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Agios Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
2 filings
1 insider, $1.06M in total
Insiders trading
1
Net value
−$1.06M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Agios Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Agios Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Gheuens SarahChief Medical Officer54,645Aug 6, 20269
Backstrom Jay T.Director1,447Jul 10, 20262
Capello Jeffrey DDirector10,865Jun 23, 20262
Foster-Cheek Kaye IDirector10,284Jun 23, 20261
Fouse Jacqualyn ADirector154,156Jun 23, 20261
Goff BrianChief Executive Officer184,508Jun 23, 20264
Smith CynthiaDirector15,230Jun 23, 20261
Ho MaykinDirector19,848Jun 23, 20261
Scadden DavidDirector20,419Jun 23, 20264
Ballal Rahul D.Director15,230Jun 23, 20261
Owen Catherine E.Director10,865Jun 23, 20262
Jones CeciliaChief Financial Officer54,998Jun 23, 20265
Burns James WilliamChief Legal Officer49,306Jun 23, 20264
Milanova TsvetaChief Commercial Officer46,829Jun 23, 20265
Viswanadhan KrishnanChief Strategy and Operations10,282Jun 23, 20264
Washburn Theodore James Jr.Principal Accounting Officer868Mar 5, 20262
Schenkein David PDirector126,242Jun 24, 20240
Poddar RichaChief Commercial Officer8,508Oct 18, 20220
Maraganore JohnDirector30,028Jun 23, 20220
Clancy Paul JDirector6,549Jun 23, 20220
Clark Ian TDirector6,549May 24, 20220
Biller JonathanChief Financial Officer22,953Mar 3, 20220
Car BruceChief Scientific Officer16,752Mar 3, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 6, 2026 (view filing)4:13 PM ETAug 42 daysGheuens SarahChief Medical OfficerSSale−30.0K$30.48−$914.4K−35.4%54.6K after10b5-1
Jul 2, 2026 (view filing)4:03 PM ETJul 11 dayGheuens SarahChief Medical OfficerSSale−4.01K$37.56−$150.5K−4.5%84.6K after10b5-1
Apr 6, 2026 (view filing)Apr 24 daysBurns James WilliamChief Legal OfficerSSale−3.28K$34.71−$113.8K−6.2%49.3K after10b5-1
Apr 6, 2026 (view filing)Apr 24 daysGheuens SarahChief Medical OfficerSSale−2.94K$34.71−$102.0K−3.5%80.3K after10b5-1
Apr 6, 2026 (view filing)Apr 24 daysJones CeciliaChief Financial OfficerSSale−3.14K$34.71−$109.0K−5.4%55.0K after10b5-1
Apr 6, 2026 (view filing)Apr 24 daysMilanova TsvetaChief Commercial OfficerSSale−3.26K$34.71−$113.2K−6.5%46.8K after10b5-1
Apr 6, 2026 (view filing)Apr 24 daysViswanadhan KrishnanChief Corp Dev & StrategySSale−2.96K$34.71−$102.7K−22.3%10.3K after10b5-1
Apr 6, 2026 (view filing)Apr 24 daysGoff BrianChief Executive OfficerSSale−19.1K$34.71−$661.9K−9.4%184.5K after2 lots10b5-1
Mar 9, 2026 (view filing)Mar 54 daysViswanadhan KrishnanChief Corp Dev & StrategySSale−2.96K$27.80−$82.3K−36.5%5.14K after10b5-1
Mar 5, 2026 (view filing)Mar 32 daysWashburn Theodore James Jr.Principal Accounting OfficerSSale−5.27K$28.88−$152.3K−85.9%868 after
Mar 3, 2026 (view filing)Mar 21 dayGoff BrianChief Executive OfficerSSale−18.1K$28.96−$522.9K−9.9%164.5K after3 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayBurns James WilliamChief Legal OfficerSSale−5.22K$28.96−$151.1K−10.6%44.1K after4 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayGheuens SarahChief Medical OfficerSSale−4.05K$28.96−$117.4K−5.2%74.4K after3 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayJones CeciliaChief Financial OfficerSSale−5.04K$28.96−$145.8K−9.3%49.3K after4 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayMilanova TsvetaChief Commercial OfficerSSale−2.87K$28.96−$83.1K−6.5%41.6K after2 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayWashburn Theodore James Jr.Principal Accounting OfficerSSale−2.22K$28.96−$64.4K−26.6%6.14K after3 lots10b5-1
Jan 7, 2026 (view filing)Jan 52 daysMilanova TsvetaChief Commercial OfficerSSale−2.87K$27.02−$77.6K−7.6%34.8K after10b5-1
Jan 2, 2026 (view filing)Dec 30, 20253 daysBurns James WilliamChief Legal OfficerSSale−2.93K$27.09−$79.4K−8.5%31.7K after10b5-1
Jan 2, 2026 (view filing)Dec 30, 20253 daysGoff BrianChief Executive OfficerSSale−18.7K$27.09−$506.7K−11.6%143.1K after2 lots10b5-1
Jan 2, 2026 (view filing)Dec 30, 20253 daysGheuens SarahChief Medical OfficerSSale−2.93K$27.09−$79.4K−4.3%64.8K after10b5-1
Jan 2, 2026 (view filing)Dec 30, 20253 daysMilanova TsvetaChief Commercial OfficerSSale−2.93K$27.09−$79.4K−9.1%29.2K after10b5-1
Jan 2, 2026 (view filing)Dec 30, 20253 daysJones CeciliaChief Financial OfficerSSale−2.93K$27.09−$79.4K−7.3%37.4K after10b5-1
Nov 14, 2025 (view filing)Nov 122 daysScadden DavidDirectorSSale−200$43.84−$8.77K−1.1%17.6K after10b5-1
Nov 13, 2025 (view filing)Nov 112 daysGheuens SarahChief Medical OfficerSSale−2.45K$43.78−$107.4K−3.8%61.7K after10b5-1
Nov 3, 2025 (view filing)Oct 304 daysGheuens SarahChief Medical OfficerSSale−200$43.81−$8.76K−0.3%61.7K after10b5-1
Oct 29, 2025 (view filing)Oct 272 daysGheuens SarahChief Medical OfficerSSale−3.30K$43.92−$145.0K−5.1%61.7K after10b5-1
Oct 10, 2025 (view filing)Oct 82 daysScadden DavidDirectorSSale−200$41.00−$8.20K−1.1%17.6K after10b5-1
Oct 2, 2025 (view filing)Sep 302 daysScadden DavidDirectorSSale−200$40.00−$8.00K−1.1%17.6K after10b5-1
Sep 30, 2025 (view filing)Sep 264 daysJones CeciliaChief Financial OfficerSSale−3.65K$36.77−$134.2K−9.7%33.9K after10b5-1
Sep 9, 2025 (view filing)Sep 54 daysWashburn Theodore James Jr.Principal Accounting OfficerSSale−8.55K$36.87−$315.1K−90.8%868 after
Aug 29, 2025 (view filing)Aug 272 daysScadden DavidDirectorSSale−200$40.00−$8.00K−1.1%17.6K after10b5-1
Aug 12, 2025 (view filing)Aug 84 daysGoff BrianChief Executive OfficerSSale−11.1K$36.67−$406.5K−8.2%123.5K after10b5-1
Jul 15, 2025 (view filing)Jul 105 daysLateScadden DavidDirectorSSale−1.40K$40.00−$56.0K−7.4%17.6K after10b5-1
Jul 11, 2025 (view filing)Jul 92 daysGheuens SarahChief Medical OfficerSSale−11.9K$37.99−$452.6K−16.3%61.3K after2 lots10b5-1
Jul 3, 2025 (view filing)Jul 12 daysGheuens SarahChief Medical OfficerSSale−4.09K$34.17−$139.8K−6.3%61.3K after10b5-1
Jun 26, 2025 (view filing)Jun 242 daysBurns James WilliamChief Legal OfficerSSale−2.80K$33.54−$93.9K−8.9%28.6K after10b5-1
Jun 26, 2025 (view filing)Jun 242 daysGheuens SarahChief Medical OfficerSSale−2.91K$33.54−$97.6K−4.9%57.0K after10b5-1
Jun 26, 2025 (view filing)Jun 242 daysJones CeciliaChief Financial OfficerSSale−1.78K$33.54−$59.7K−5.6%30.0K after10b5-1
Jun 26, 2025 (view filing)Jun 242 daysMilanova TsvetaChief Commercial OfficerSSale−2.77K$33.54−$92.9K−9.6%26.1K after10b5-1
Jun 26, 2025 (view filing)Jun 242 daysGoff BrianChief Executive OfficerSSale−18.7K$33.54−$627.2K−14.3%111.9K after2 lots10b5-1
Apr 10, 2025 (view filing)Apr 10Same dayFouse Jacqualyn ADirectorSSale−7.50K$25.90−$194.2K−4.8%149.2K after10b5-1
Mar 4, 2025 (view filing)Mar 31 dayBurns James WilliamChief Legal OfficerSSale−4.00K$35.54−$142.3K−13.6%25.4K after3 lots10b5-1
Mar 4, 2025 (view filing)Mar 31 dayJones CeciliaChief Financial OfficerSSale−2.27K$35.54−$80.9K−8.1%25.8K after2 lots10b5-1
Mar 4, 2025 (view filing)Mar 31 dayMilanova TsvetaChief Commercial OfficerSSale−1.68K$35.54−$59.7K−6.8%22.9K after10b5-1
Mar 4, 2025 (view filing)Mar 31 dayGoff BrianChief Executive OfficerSSale−12.9K$35.54−$460.1K−12.3%92.3K after2 lots10b5-1
Mar 4, 2025 (view filing)Mar 31 dayGheuens SarahChief Medical OfficerSSale−4.00K$35.54−$142.3K−6.9%53.9K after3 lots10b5-1
Mar 4, 2025 (view filing)Mar 31 dayWashburn Theodore James Jr.Principal Accounting OfficerSSale−1.66K$35.54−$58.8K−15.0%9.41K after3 lots10b5-1
Feb 5, 2025 (view filing)Feb 5Same dayWashburn Theodore James Jr.Principal Accounting OfficerSSale−2.27K$34.39−$78.1K−29.5%5.44K after10b5-1
Jan 7, 2025 (view filing)Jan 61 dayMilanova TsvetaChief Commercial OfficerSSale−2.80K$32.18−$90.2K−12.9%18.9K after10b5-1
Dec 13, 2024 (view filing)Dec 112 daysScadden DavidDirectorSSale−200$46.28−$9.26K−1.3%15.5K after10b5-1